Posted on September 15th, 2014 | By Bill W. Hornaday
As the newest member of the OVPE team, Joe Carley brings 10 years of combined planning, zoning and economic development experience in three states to Innovate Indiana’s mission of fostering statewide economic growth.
In his role as Assistant Director for Economic Development, Carley — a recent graduate of Indiana University’s Maurer School of Law — works closely with Kirk White, who serves as OVPE’s Assistant Vice President for Strategic Partnerships.
Some of Carley’s early efforts include working with Bloomington leaders who envision a technology “corridor” that would extend from the City of Bloomington’s Innovation District downtown along 10th Street to the IU Technology Park. He is also working to support land-use and economic development studies focused on the new Interstate 69 corridor in southwest Indiana and the Naval Surface Warfare Center near Crane.
“We’re hoping to find ways to make these areas more connected with prospective employees and the overall work force so we can maximize the opportunities that I-69 may bring,” Carley said.
Read more about Joe and his background here.
Posted on September 12th, 2014 | By Bill W. Hornaday
The Judd Leighton School of Business and Economics at Indiana University South Bend recently launched its 12th Annual Entrepreneur Lecture Series, with this fall’s theme titled “Entrepreneurship: Inspiring Creativity and Innovation.”
Each lecture begins at 7 p.m. each Thursday through Nov. 13 in Room 1011 of IU South Bend’s Education and Arts Building (shown above) at 1002 S. Esther St., with parking lots available nearby. The series features many of northern Indiana’s premier business organizations and key leaders, and their insights on today’s business environment.
Learn more about the Entrepreneur Lecture Series and its upcoming speakers and topics here:
Posted on September 12th, 2014 | By Bill W. Hornaday
PrecisionHawk, an IU-funded venture that uses unmanned aerial vehicles (UAVs) and plug-and-play sensors to collect and process data for various commercial uses, is one of 10 Indiana Innovation Award winners for 2014.
Presented by Centric, Indy’s Innovation Program, the award honors companies with Indiana operations that have launched a successful or innovative product or service within the past three years. One hundred companies were nominated for the awards, now in their fourth year.
The Innovate Indiana Fund, administered by the Indiana University Research and Technology Corp. (IURTC), is among PrecisionHawk’s lead investors. Data collected by the company’s UAVs are used in such industries as agriculture, oil and gas, insurance, forestry and utilities, and in such applications as environmental science, geology and disaster response.
Read more about PrecisionHawk here:
Posted on September 10th, 2014 | By Innovate Indiana
Recognizing the contributing role Indiana’s research universities play in introducing innovative technologies and spurring economic growth, Indiana’s Senator Dan Coats recently co-introduced bipartisan legislation designed to enhance the effectiveness of the Small Business Technology Transfer (STTR) program.
The Technology and Research Accelerating National Security and Future Economic Resiliency (TRANSFER) Act would facilitate proof-of-concept research and other innovative technology transfer activities at universities, research institutes and federal laboratories, to accelerate the commercialization of federally funded research and technologies.
The bill builds on the existing STTR program by opening grant opportunities to early-stage concepts and technologies, directly benefiting Indiana’s state universities and research institutes as they strive to overcome significant hurdles faced in transitioning nascent research and technologies into the marketplace.
Posted on August 13th, 2014 | By Innovate Indiana
An Indiana University biochemist’s discovery of a class of anti-viral small molecules that target the function of a virus DNA hidden in the infected livers of hepatitis B patients may lead to a cure for this viral infection that kills more than 600,000 people annually.
Adam Zlotnick, a professor of molecular and cellular biochemistry in the IU Bloomington College of Arts and Sciences, and four colleagues — chemistry professor Richard DiMarchi and biochemistry visiting scholar William Turner, both of IU Bloomington; Indianapolis biotechnology entrepreneur Derek Small; and infectious disease researcher Dr. Uri Lopatin — formed Assembly Pharmaceuticals in 2012 to develop new anti-viral drugs based on Zlotnick’s discoveries. Novel compounds based on these discoveries, known as Core Protein Allosteric Modulators, or CpAMs, are capable of altering the activities of a core hepatitis B protein that is essential for the virus’s continued survival.
Despite the early stage of its pipeline, the promise of Assembly’s novel approach attracted the interest of Nasdaq-listed Ventrus Biosciences. Last week, Ventrus stockholders voted to merge with Assembly to form a new company, Assembly Biosciences, which is now trading on Nasdaq under the ticker “ASMB,” catapulting the firm from new start-up to public company in less than two years.